Submission for OMB Review; 30-Day Comment Request; Cancer Epidemiology Descriptive Cohort Database (NCI), 54731-54732 [2014-21785]
Download as PDF
Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices
Drive, MSC 9761, Room 3E610,
Rockville, MD 20850 or call non-toll
free number 240–276–6721 or Email
your request, including your address, to
hesseb@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Proposed Collection: Food and Drug
Administration (FDA) and the National
Cancer Institute (NCI) Health
Communication Survey (FDA–NCI),
0925–NEW, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
54731
will extend the information collected
and priorities from the Health
Information National Trends Survey
(HINTS) which has been to provide a
comprehensive assessment of the
American public’s current access to, and
use of, information about cancer across
the cancer care continuum from cancer
prevention, early detection, diagnosis,
treatment, and survivorship.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 2,159.
Need and Use of Information
Collection: This partnership between
NCI and FDA will include assessing the
public’s knowledge of medical devices,
communications related to product
recalls, nutritional supplement labeling,
and topics to inform FDA’s regulatory
authority over tobacco, such as risk
perceptions about new tobacco products
and labels. This NCI–FDA survey will
couple knowledge-related questions
with inquiries into the communication
channels through which understanding
is being obtained, and assessment of
FDA-regulated material. This survey
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden
hour
Individuals ........................................................................................................
4,318
1
30/60
2,159
Dated: September 8, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–21783 Filed 9–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Cancer
Epidemiology Descriptive Cohort
Database (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on June 18, 2014,
Vol. 79, page 34766 and allowed 60days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:58 Sep 11, 2014
Jkt 232001
Direct Comments To OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Daniela Seminara, Senior
Scientist and Cohort and Consortia
Coordination Team Lead, Epidemiology
and Genomics Research Program
(EGRP), Division of Cancer Control and
Population Sciences (DCCPS), 9609
Medical Center Drive, Rockville, Md.
20892 or call non-toll-free number 240–
276–6748 or email your request,
including your address to:
seminard@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Cancer
Epidemiology Descriptive Cohort
Database, 0925—New, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The NCI Epidemiology and
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Genomics Research Program (EGRP)
supports large-scale collaborations
across numerous cancer epidemiology
cohorts. The collaborative approach to
date has been lacking in easily
accessible, centralized, and searchable
information. To address the need for
better collaborative research and
increased transparency, EGRP will
develop a Cancer Epidemiology
Descriptive Cohort Database (CEDCD)
accessible through a public Web site.
The information collected from the
current survey will be used to populate
the CEDCD. This public Web site will
allow investigators to know what data
and specimens exist among other
cohorts. Respondents will be cohort
Principal Investigators. The data
collection forms will be sent to
participating cohort PIs annually to
update any information that has
changed so that the CEDCD Web site
will remain current. No cohort
participant-level data is being collected
from any of the cohorts.
The information to be collected will
be aggregate descriptive information and
protocols. Though the CEDCD has a
biospecimen component (similar to the
Specimen Resource Locator), the
CEDCD is not a biospecimen locator
database. It is a database focusing
exclusively on descriptive data
pertaining to large, prospective
epidemiology cohorts.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
550.
E:\FR\FM\12SEN1.SGM
12SEN1
54732
Federal Register / Vol. 79, No. 177 / Friday, September 12, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Individual: Principal Investigator New
Cohort.
Approval Form ..................................
Biospecimen and Cancer Count Information Spreadsheet.
Cancer Epidemiology Descriptive
Cohort Database Data Collection
Form.
Biospecimen and Cancer Count Information Spreadsheet.
Cancer Epidemiology Descriptive
Cohort Database Data Collection
Form.
Individual: Principal Investigator Established Cohort.
Dated: September 8, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–21785 Filed 9–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical, Treatment and
Health Sciences Research Review
Subcommittee.
Date: October 15, 2014.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
proposals.
Place: NIAAA, NIH, 5635 Fishers Lane,
Terrace Level Conference Room, Rockville,
MD 20852.
Contact Person: Katrina L. Foster, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, NIH,
5635 Fishers Lane; Room 2019, Rockville,
MD 20852, (301) 443–4032,
katrina@mail.nih.gov.
VerDate Mar<15>2010
17:58 Sep 11, 2014
Jkt 232001
Frm 00056
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Total annual
burden hour
100
100
1
1
30/60
60/60
50
100
100
1
90/60
150
200
1
30/60
100
200
1
45/60
150
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Review
Subcommittee.
Date: October 21, 2014.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
proposals.
Place: NIAAA, NIH, 5635 Fishers Lane,
Terrace Level Conference Room, Rockville,
MD 20852.
Contact Person: Philippe Marmillot, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, NIH,
5635 Fishers Lane; Room 2017, Rockville,
MD 20852, (301) 443–2861,
marmillotp@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: October 22, 2014.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
proposals.
Place: NIAAA, 5635 Fishers Lane, Terrace
Level Conference Room, Rockville, MD
20852.
Contact Person: Katrina L. Foster, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, NIH,
5635 Fishers Lane; Room 2019, Rockville,
MD 20852, (301) 443–4032,
katrina@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: November 4–5, 2014.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
proposals.
Place: NIAAA, NIH, 5635 Fishers Lane,
Terrace Level Conference Room, Rockville,
MD 20852.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, NIH,
5635 Fishers Lane; Room 2081, Rockville,
MD 20852, (301) 443–0800,
bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
PO 00000
Number of
responses per
respondent
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 92.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Supports Awards, National
Institutes of Health, HHS)
Dated: September 8, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–21721 Filed 9–11–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel;
Affordable Hearing.
Date: October 15, 2014.
Time: 11 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
E:\FR\FM\12SEN1.SGM
12SEN1
Agencies
[Federal Register Volume 79, Number 177 (Friday, September 12, 2014)]
[Notices]
[Pages 54731-54732]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21785]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Cancer
Epidemiology Descriptive Cohort Database (NCI)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH), has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on June 18, 2014, Vol. 79, page 34766 and allowed 60-days for
public comment. No public comments were received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Cancer Institute (NCI), National Institutes of Health, may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a currently
valid OMB control number.
Direct Comments To OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRAsubmission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project contact: Daniela Seminara, Senior Scientist and Cohort
and Consortia Coordination Team Lead, Epidemiology and Genomics
Research Program (EGRP), Division of Cancer Control and Population
Sciences (DCCPS), 9609 Medical Center Drive, Rockville, Md. 20892 or
call non-toll-free number 240-276-6748 or email your request, including
your address to: seminard@mail.nih.gov. Formal requests for additional
plans and instruments must be requested in writing.
Proposed Collection: Cancer Epidemiology Descriptive Cohort
Database, 0925--New, National Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information Collection: The NCI Epidemiology and
Genomics Research Program (EGRP) supports large-scale collaborations
across numerous cancer epidemiology cohorts. The collaborative approach
to date has been lacking in easily accessible, centralized, and
searchable information. To address the need for better collaborative
research and increased transparency, EGRP will develop a Cancer
Epidemiology Descriptive Cohort Database (CEDCD) accessible through a
public Web site. The information collected from the current survey will
be used to populate the CEDCD. This public Web site will allow
investigators to know what data and specimens exist among other
cohorts. Respondents will be cohort Principal Investigators. The data
collection forms will be sent to participating cohort PIs annually to
update any information that has changed so that the CEDCD Web site will
remain current. No cohort participant-level data is being collected
from any of the cohorts.
The information to be collected will be aggregate descriptive
information and protocols. Though the CEDCD has a biospecimen component
(similar to the Specimen Resource Locator), the CEDCD is not a
biospecimen locator database. It is a database focusing exclusively on
descriptive data pertaining to large, prospective epidemiology cohorts.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 550.
[[Page 54732]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individual: Principal Approval Form... 100 1 30/60 50
Investigator New Cohort. Biospecimen and 100 1 60/60 100
Cancer Count
Information
Spreadsheet.
Cancer 100 1 90/60 150
Epidemiology
Descriptive
Cohort Database
Data Collection
Form.
Individual: Principal Biospecimen and 200 1 30/60 100
Investigator Established Cancer Count
Cohort. Information
Spreadsheet.
Cancer 200 1 45/60 150
Epidemiology
Descriptive
Cohort Database
Data Collection
Form.
----------------------------------------------------------------------------------------------------------------
Dated: September 8, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-21785 Filed 9-11-14; 8:45 am]
BILLING CODE 4140-01-P